226 related articles for article (PubMed ID: 9810337)
1. Initial experience with quality assurance of multi-institutional 3D radiotherapy clinical trials. A brief report.
Purdy JA; Harms WB; Michalski J; Bosch WR
Strahlenther Onkol; 1998 Oct; 174 Suppl 2():40-2. PubMed ID: 9810337
[TBL] [Abstract][Full Text] [Related]
2. Quality assurance issues in conducting multi-institutional advanced technology clinical trials.
Purdy JA
Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S66-70. PubMed ID: 18406941
[TBL] [Abstract][Full Text] [Related]
3. Quality assurance for 3D conformal radiation therapy.
Purdy JA; Harms WB
Strahlenther Onkol; 1998 Oct; 174 Suppl 2():2-7. PubMed ID: 9810330
[TBL] [Abstract][Full Text] [Related]
4. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
Hein PA; Gladstone DJ; Bellerive MR; Hug EB
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
[TBL] [Abstract][Full Text] [Related]
5. Detailed review and analysis of complex radiotherapy clinical trial planning data: evaluation and initial experience with the SWAN software system.
Ebert MA; Haworth A; Kearvell R; Hooton B; Coleman R; Spry N; Bydder S; Joseph D
Radiother Oncol; 2008 Feb; 86(2):200-10. PubMed ID: 18077034
[TBL] [Abstract][Full Text] [Related]
6. A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319.
Vicini F; Winter K; Straube W; Wong J; Pass H; Rabinovitch R; Chafe S; Arthur D; Petersen I; McCormick B
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1531-7. PubMed ID: 16198508
[TBL] [Abstract][Full Text] [Related]
7. The quality assurance process for the ARTSCAN head and neck study - a practical interactive approach for QA in 3DCRT and IMRT.
Johansson KA; Nilsson P; Zackrisson B; Ohlson B; Kjellén E; Mercke C; Alvarez-Fonseca M; Billström A; Björk-Eriksson T; Björ O; Ekberg L; Friesland S; Karlsson M; Lagerlund M; Lundkvist L; Löfroth PO; Löfvander-Thapper K; Nilsson A; Nyman J; Persson E; Reizenstein J; Rosenbrand HO; Wiklund F; Wittgren L
Radiother Oncol; 2008 May; 87(2):290-9. PubMed ID: 18206256
[TBL] [Abstract][Full Text] [Related]
8. Quality assurance in the prospective multi-institutional trial on definitive radiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer: the individual case review.
Toita T; Oguchi M; Ohno T; Kato S; Niibe Y; Kodaira T; Kazumoto T; Kataoka M; Shikama N; Kenjo M; Teshima T; Kagami Y
Jpn J Clin Oncol; 2009 Dec; 39(12):813-9. PubMed ID: 19815538
[TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh.
Hong L; Alektiar KM; Hunt M; Venkatraman E; Leibel SA
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):752-9. PubMed ID: 15183478
[TBL] [Abstract][Full Text] [Related]
10. High conformality radiotherapy in Europe: thirty-one centres participating in the quality assurance programme of the EORTC prostate trial 22991.
Ataman F; Poortmans P; Davis JB; Bernier J; Giraud JY; Kouloulias VE; Pierart M; Bolla M
Eur J Cancer; 2004 Nov; 40(16):2411-6. PubMed ID: 15519513
[TBL] [Abstract][Full Text] [Related]
11. Process control analysis of IMRT QA: implications for clinical trials.
Pawlicki T; Yoo S; Court LE; McMillan SK; Rice RK; Russell JD; Pacyniak JM; Woo MK; Basran PS; Boyer AL; Bonilla C
Phys Med Biol; 2008 Sep; 53(18):5193-205. PubMed ID: 18728311
[TBL] [Abstract][Full Text] [Related]
12. Initial experience with the quality assurance program of radiation therapy on behalf of Japan Radiation Oncology Group (JAROG).
Isobe K; Kagami Y; Higuchi K; Kodaira T; Hasegawa M; Shikama N; Nakazawa M; Fukuda I; Nihei K; Ito K; Teshima T; Oguchi M;
Jpn J Clin Oncol; 2007 Feb; 37(2):135-9. PubMed ID: 17255160
[TBL] [Abstract][Full Text] [Related]
13. Assuring high quality treatment delivery in clinical trials - Results from the Trans-Tasman Radiation Oncology Group (TROG) study 03.04 "RADAR" set-up accuracy study.
Haworth A; Kearvell R; Greer PB; Hooton B; Denham JW; Lamb D; Duchesne G; Murray J; Joseph D
Radiother Oncol; 2009 Mar; 90(3):299-306. PubMed ID: 19017549
[TBL] [Abstract][Full Text] [Related]
14. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
[TBL] [Abstract][Full Text] [Related]
15. Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review.
Matzinger O; Poortmans P; Giraud JY; Maingon P; Budiharto T; van den Bergh AC; Davis JB; Musat E; Ataman F; Huyskens DP; Gulyban A; Bolla M;
Radiother Oncol; 2009 Mar; 90(3):285-90. PubMed ID: 19038468
[TBL] [Abstract][Full Text] [Related]
16. 3D dose reconstruction for clinical evaluation of IMRT pretreatment verification with an EPID.
van Zijtveld M; Dirkx ML; de Boer HC; Heijmen BJ
Radiother Oncol; 2007 Feb; 82(2):201-7. PubMed ID: 17287039
[TBL] [Abstract][Full Text] [Related]
17. Quality assurance for prospective EORTC radiation oncology trials: the challenges of advanced technology in a multicenter international setting.
Weber DC; Poortmans PM; Hurkmans CW; Aird E; Gulyban A; Fairchild A
Radiother Oncol; 2011 Jul; 100(1):150-6. PubMed ID: 21722980
[TBL] [Abstract][Full Text] [Related]
18. Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group.
Eich HT; Staar S; Gossmann A; Hansemann K; Skripnitchenko R; Kocher M; Semrau R; Engert A; Josting A; Franklin J; Krug B; Diehl V; Müller RP;
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1121-7. PubMed ID: 15001253
[TBL] [Abstract][Full Text] [Related]
19. Quality assurance of the 22961 EORTC trial. A phase III study of the optimal combination of hormonal adjuvant treatment by LHRH analogue and radiation therapy for the management of locally advanced prostate cancer: the dummy run.
Kouloulias VE; Giraud JY; Davis BJ; Dusserre A; Zurlo A; Bolla M
Radiother Oncol; 2004 Oct; 73(1):11-20. PubMed ID: 15465141
[TBL] [Abstract][Full Text] [Related]
20. Implementation of remote 3-dimensional image guided radiation therapy quality assurance for radiation therapy oncology group clinical trials.
Cui Y; Galvin JM; Parker W; Breen S; Yin FF; Cai J; Papiez LS; Li XA; Bednarz G; Chen W; Xiao Y
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):271-7. PubMed ID: 22541964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
